Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
Top Cited Papers
Open Access
- 20 May 2016
- journal article
- case report
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 7 (1), 11589
- https://doi.org/10.1038/ncomms11589
Abstract
Resistance to the Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib has been attributed solely to mutations in BTK and related pathway molecules. Using whole-exome and deep-targeted sequencing, we dissect evolution of ibrutinib resistance in serial samples from five chronic lymphocytic leukaemia patients. In two patients, we detect BTK-C481S mutation or multiple PLCG2 mutations. The other three patients exhibit an expansion of clones harbouring del(8p) with additional driver mutations (EP300, MLL2 and EIF2A), with one patient developing trans-differentiation into CD19-negative histiocytic sarcoma. Using droplet-microfluidic technology and growth kinetic analyses, we demonstrate the presence of ibrutinib-resistant subclones and estimate subclone size before treatment initiation. Haploinsufficiency of TRAIL-R, a consequence of del(8p), results in TRAIL insensitivity, which may contribute to ibrutinib resistance. These findings demonstrate that the ibrutinib therapy favours selection and expansion of rare subclones already present before ibrutinib treatment, and provide insight into the heterogeneity of genetic changes associated with ibrutinib resistance.Keywords
This publication has 44 references indexed in Scilit:
- Methods for qPCR gene expression profiling applied to 1440 lymphoblastoid single cellsMethods, 2013
- A Hypermorphic Missense Mutation in PLCG2, Encoding Phospholipase Cγ2, Causes a Dominantly Inherited Autoinflammatory Disease with ImmunodeficiencyAmerican Journal of Human Genetics, 2012
- Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencingProceedings of the National Academy of Sciences of the United States of America, 2012
- Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven casesLaboratory Investigation, 2011
- Initial genome sequencing and analysis of multiple myelomaNature, 2011
- The genomic complexity of primary human prostate cancerNature, 2011
- Integrative genomics viewerNature Biotechnology, 2011
- The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancyProceedings of the National Academy of Sciences of the United States of America, 2010
- Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemiaBlood, 2010
- Fast and accurate long-read alignment with Burrows–Wheeler transformBioinformatics, 2010